129 related articles for article (PubMed ID: 28361043)
21. Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptor.
Frigault MM; Naujokas MA; Park M
J Cell Physiol; 2008 Mar; 214(3):694-705. PubMed ID: 17894413
[TBL] [Abstract][Full Text] [Related]
22. Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections.
Fitzgerald KD; Chase AJ; Cathcart AL; Tran GP; Semler BL
J Virol; 2013 Mar; 87(5):2390-400. PubMed ID: 23255796
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis.
Fung G; Shi J; Deng H; Hou J; Wang C; Hong A; Zhang J; Jia W; Luo H
Cell Death Differ; 2015 Dec; 22(12):2087-97. PubMed ID: 25976304
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
Martin U; Jarasch N; Nestler M; Rassmann A; Munder T; Seitz S; Zell R; Wutzler P; Henke A
Apoptosis; 2007 Mar; 12(3):525-33. PubMed ID: 17211569
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes.
Luo H; Zhang J; Cheung C; Suarez A; McManus BM; Yang D
Am J Pathol; 2003 Aug; 163(2):381-5. PubMed ID: 12875959
[TBL] [Abstract][Full Text] [Related]
27. Polypyrimidine tract-binding protein (PTB) and PTB-associated splicing factor in CVB3 infection: an ITAF for an ITAF.
Dave P; George B; Sharma DK; Das S
Nucleic Acids Res; 2017 Sep; 45(15):9068-9084. PubMed ID: 28633417
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
29. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
30. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
[TBL] [Abstract][Full Text] [Related]
31. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.
Si X; Luo H; Morgan A; Zhang J; Wong J; Yuan J; Esfandiarei M; Gao G; Cheung C; McManus BM
J Virol; 2005 Nov; 79(22):13875-81. PubMed ID: 16254323
[TBL] [Abstract][Full Text] [Related]
32. Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).
Park N; Schweers NJ; Gustin KE
J Virol; 2015 Nov; 89(21):11069-79. PubMed ID: 26311873
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections.
Rai DK; Lawrence P; Kloc A; Schafer E; Rieder E
Virol J; 2015 Dec; 12():224. PubMed ID: 26695943
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.
Si X; Wang Y; Wong J; Zhang J; McManus BM; Luo H
J Virol; 2007 Apr; 81(7):3142-50. PubMed ID: 17229707
[TBL] [Abstract][Full Text] [Related]
35. Expression and purification of recombinant 3C proteinase of Coxsackievirus B3.
Miyashita K; Kusumi M; Utsumi R; Komano T; Satoh N
Biosci Biotechnol Biochem; 1992 May; 56(5):746-50. PubMed ID: 1369382
[TBL] [Abstract][Full Text] [Related]
36. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
[TBL] [Abstract][Full Text] [Related]
37. Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk.
Deutschmann-Olek KM; Yue WW; Bezerra GA; Skern T
Virology; 2021 Oct; 562():128-141. PubMed ID: 34315103
[TBL] [Abstract][Full Text] [Related]
38. Blocking human enterovirus 71 replication by targeting viral 2A protease.
Falah N; Montserret R; Lelogeais V; Schuffenecker I; Lina B; Cortay JC; Violot S
J Antimicrob Chemother; 2012 Dec; 67(12):2865-9. PubMed ID: 22865380
[TBL] [Abstract][Full Text] [Related]
39. Coxsackievirus B3 replication and pathogenesis.
Garmaroudi FS; Marchant D; Hendry R; Luo H; Yang D; Ye X; Shi J; McManus BM
Future Microbiol; 2015; 10(4):629-53. PubMed ID: 25865198
[TBL] [Abstract][Full Text] [Related]
40. Viral protease cleavage of inhibitor of kappaBalpha triggers host cell apoptosis.
Zaragoza C; Saura M; Padalko EY; Lopez-Rivera E; Lizarbe TR; Lamas S; Lowenstein CJ
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19051-6. PubMed ID: 17138672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
